NCT00003472View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Oligodendroglioma, Adult
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Adults with a recurrent/progressive Oligodendroglioma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER